Loading organizations...
§ Venture Capital · Bredgade 40 DK-1260 Copenhagen K Denmark
Danish venture capital firm that invested in early-stage life sciences companies in Europe until its 2007 spin-out.
BankInvest Biomedical Venture operates as a venture capital entity focused on identifying and nurturing growth-stage companies within the life science sector. The firm specializes in providing substantial capital to biomedical enterprises, enabling the development and scaling of critical innovations. Its investment approach emphasizes strategic partnerships with promising ventures, extending beyond mere financial backing to support the advancement of scientific breakthroughs into viable solutions.
This specialized venture arm was established in 1998 by BankInvest, a Danish asset management firm founded in 1969. The insight behind its creation stemmed from recognizing the significant potential within the nascent biotechnology industry and the need for dedicated financial expertise to support its complex development cycles. By leveraging BankInvest's established financial acumen, the venture aimed to bridge the gap between scientific discovery and market realization.
BankInvest Biomedical Venture's clientele comprises a range of emerging biomedical companies actively developing new therapies, diagnostics, and medical technologies. The firm's vision centers on fostering a robust ecosystem of life science innovation by providing essential resources to these enterprises. It aims to contribute to long-term progress in healthcare by supporting companies that can deliver impactful solutions to global health challenges.
BankInvest Biomedical Venture has 1 tracked investment across 1 company. The latest tracked deal is $45.0M Series D in Nereus Pharmaceuticals in August 2007.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Aug 9, 2007 | Nereus Pharmaceuticals | $45.0M Series D | Bankinvest Biomedical Venture | Advent International, Alta Partners, Astellas Venture Management, Boston Life Science Venture Corporation, Eminent II Venture Capital, Forward Ventures, GIMV, HBM Healthcare Investments, Interwest Partners, Pacific Venture Group, Roche, Taiwan Global Biofund |